Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis

被引:171
|
作者
Raitanen, MP
Aine, R
Rintala, E
Kallio, J
Rajala, P
Juusela, H
Tammela, TLJ
机构
[1] Seinajoki Cent Hosp, Surg Clin, Dept Urol, Seinajoki 60220, Finland
[2] Tampere Univ Hosp, Dept Pathol, Tampere, Finland
[3] Helsinki Univ Hosp, Dept Urol, Helsinki, Finland
[4] Tampere Univ Hosp, Dept Urol, Tampere, Finland
[5] Turku Univ Hosp, Div Urol, FIN-20520 Turku, Finland
[6] Jorvi Hosp, Div Urol, Espoo, Finland
[7] Tampere Univ, Dept Urol, FIN-33101 Tampere, Finland
[8] Tampere Univ, Sch Med, FIN-33101 Tampere, Finland
关键词
bladder neoplasm; urine cytology; marker;
D O I
10.1016/S0302-2838(02)00006-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The objective of the study is to evaluate the agreement of local and review urinary cytology in patients with newly diagnosed bladder cancer and in those being followed for their disease. In addition, the effect of the type of institution on agreement was determined. Methods: A total of 652 consecutive patients with bladder cancer from 19 institutions were evaluated; 575 (88.2%) of the patients had cytopathological sample available for central review and were eligible for analysis. One hundred and twenty nine (22.4%) of the patients had newly diagnosed bladder cancer, whereas the remaining 446 (77.6%) patients were under follow-up. A voided urine sample was obtained prior to transurethral resection of the bladder (TURB) or routine follow-up cystoscopy and split for culture and cytology. The cytopathological samples were first analysed by a local pathologist, and then re-analysed by a central reviewer. The agreement of cytological readings was determined by Kappa coefficient, Results: The sensitivities of local and review cytology in detection of primary bladder cancer were 38.8 and 31.0%, respectively. Recurrence was observed in 119 of the 446 (26.7%) patients under follow-up, of which both local and review cytology detected 21 (17.6%) cases. Specificities of local and review cytology were 97.6 and 96.6%, respectively. Overall agreement of urine cytology was good in patients with primary bladder cancer and moderate in those being followed for their disease as Kappa coefficients were 0.70 and 0.60, respectively. However. some disagreement was found when results were analysed according to type of institution, to type of primary tumour, and to result of follow-up cystoscopy. In patients with primary bladder cancer the Kappa coefficient was 0.86 (very good) in university hospitals and 0.36 (fair) in city hospitals. Accordingly, in patients under follow-up the Kappa coefficient was 0.65 (good) in university hospitals and 0.39 (fair) in district hospitals. Although the stage of primary tumour had no effect on agreement, agreement was moderate (Kappa coefficient 0.45) in those with low grade tumour and good (Kappa coefficient 0.67) in those with high grade tumour. In addition, Kappa coefficients were 0.65 (good) and 0.40 (fair) in those with and without recurrence at follow-up cystoscopy. Conclusions: Although overall agreement of routine cytology was from moderate to good in both diagnosis and monitoring of bladder cancer, there is some variation in agreement according to the type of institution. Accordingly, grade of primary tumour and the result of follow-up cystoscopy had effect on agreement reflecting subjectiveness and weak reproducibility of this test. This not only emphasises the need for continuing education and quality control for urine cytologic analysis, but also inspires the development of more objective tests. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:284 / 289
页数:6
相关论文
共 50 条
  • [1] Cytology and Urinary Markers for the Diagnosis of Bladder Cancer
    van Rhijn, Bas W. G.
    van der Poel, Henk G.
    van der Kwast, Theo H.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (07) : 536 - 541
  • [2] Reliability of urinary cytology and cystoscopy for the screening and diagnosis of bladder cancer in patients with neurogenic bladder: A systematic review
    Alimi, Quentin
    Hascoet, Juliette
    Manunta, Andrea
    Kammerer-Jacquet, Solene-Florence
    Verhoest, Gregory
    Brochard, Charlene
    Freton, Lucas
    Kerdraon, Jacques
    Senal, Nelly
    Siproudhis, Laurent
    Rioux-Leclercq, Nathalie
    Brucker, Benjamin
    Game, Xavier
    Peyronnet, Benoit
    NEUROUROLOGY AND URODYNAMICS, 2018, 37 (03) : 916 - 925
  • [3] Voided urinary cytology in bladder cancer: Is it time to review the indications?
    Talwar, Raghav
    Sinha, Tapan
    Karan, S. C.
    Doddamani, D.
    Sandhu, A.
    Sethi, G. S.
    Srivastava, A.
    Narang, V.
    Agarwal, A.
    Adhlakha, N.
    UROLOGY, 2007, 70 (02) : 267 - 271
  • [4] SIGNIFICANCE OF URINARY CYTOLOGY AS A SCREENING-TEST FOR THE DIAGNOSIS OF URINARY-BLADDER CANCER
    DEVOOGT, HJ
    ONKOLOGIE, 1980, 3 (05): : 233 - &
  • [5] ACCURACY OF URINARY CYTOLOGY IN THE DIAGNOSIS OF PRIMARY AND RECURRENT BLADDER-CANCER
    WIENER, HG
    PETERVOOIJS, G
    VANTHOFGROOTENBOER, B
    ACTA CYTOLOGICA, 1993, 37 (02) : 163 - 169
  • [6] Urinary fluorescence analysis in diagnosis of bladder cancer
    Kollarik, B.
    Zvarik, M.
    Bujdak, P.
    Weibl, P.
    Rybar, L.
    Sikurova, L.
    Hunakova, L.
    NEOPLASMA, 2018, 65 (02) : 234 - 241
  • [7] Diagnosis of bladder cancer by analysis of urinary fibronectin
    Menéndez, V
    Fernández-Suárez, A
    Galán, JA
    Pérez, M
    García-López, F
    UROLOGY, 2005, 65 (02) : 284 - 289
  • [8] Diagnosis of bladder cancer with urinary cytology, immunocytology and DNA-image-cytometry
    Planz, B
    Synek, C
    Deix, T
    Böcking, A
    ANALYTICAL CELLULAR PATHOLOGY, 2001, 22 (03): : 103 - 109
  • [9] Urinary Biomarkers for Diagnosis of Bladder Cancer A Systematic Review and Meta-analysis
    Chou, Roger
    Gore, John L.
    Buckley, David
    Fu, Rongwei
    Gustafson, Katie
    Griffin, Jessica C.
    Grusing, Sara
    Selph, Shelley
    ANNALS OF INTERNAL MEDICINE, 2015, 163 (12) : 922 - +
  • [10] FLOW-CYTOMETRY AND URINARY CYTOLOGY IN THE DIAGNOSIS OF PATIENTS WITH BLADDER-CANCER
    MAIER, G
    BLECH, M
    DROESE, M
    RINGERT, RH
    UROLOGE-AUSGABE A, 1990, 29 (06): : 330 - 333